Address:
Tel:
Web: http://www.prima-malta.com/
The Pharmaceutical Research Based Industry Malta Association, PRIMA, is affiliated with the European Federation of Pharmaceutical Industries and Associations (EFPIA). EFPIA is the representative body of the pharmaceutical industry in Europe. Its members are the national industry associations of thirty countries in Europe and over forty leading pharmaceutical companies.
PRIMA’s primary mission is to promote pharmaceutical discovery and development in Malta and to bring to the market medicinal products in order to improve human health.
As PRIMA, we aim to foster an environment that encourages the availability of newly researched and developed medicinals and intellectual property protection. We also aim to work in collaboration with the government and non governmental bodies to allow patients rapid access to medicinal products.
PRIMA represents the R&D pharmaceutical companies operating in Malta with respect to government organizations. Our aim is to make such bodies aware of the views of the R&D pharmaceutical industry on all matters that are of interest to it and concern public health, especially international legislation and regulations. Further more we endeavour to maintain close relations with governmental bodies and also with non-governmental bodies in order to enhance understanding of problems affecting the R&D pharmaceutical industry.*
PRIMA is responsible to co-ordinate policies of member companies particularly as regards rules of conduct and self regulatory ethical codes specific to the industry and organize any exchange of information and views among members. As well as, to co-operate with international organisations having similar objectives and activities.
This association was founded by AstraZeneca, Eli Lilly, GlaxoSmithKline, Novartis, Sanofi-aventis and Wyeth on 3rd May 2006
Speaking exclusively to PharmaBoardroom Marios Themistocleous, secretary general of primary health care at the Greek Ministry of Health, introduces the transformation that primary healthcare in Greece has undergone since the…
Mohamed Ali Abd El Azim gives several insights into GSK’s sizeable production footprint in Egypt, how the organisation’s aims dovetail with Egypt’s healthcare transformation, and what makes him proud to…
Fabian Gerber of SIX Swiss Exchange, Switzerland’s principal stock exchange, outlines the importance of life sciences companies to the exchange, representing over a third of total market capitalization with the…
Anna-Kaija Grönblad, country chair Sanofi Sweden and general manager primary care Nordics & Baltics, explains the importance of Sweden for the group as an early adopter of new treatments, an…
Tan Sri Dato’ Ariffin Yusuf, founder and managing director of Primabumi, explains how he came to build Primabumi in 1975 and how he managed to position the company as a…
Nicholas Falzon and Margot Pisani, respectively president and secretary general at the Pharmaceutical Research-based Industry Malta Association (PRIMA), discuss the business environment for originators in the island as well as…
Beginning his career in Bayer Pharma Mr. Drøidal soon found his calling in management, working his way up the ranks of management in Pfizer reaching the position of Head of…
Can you give our readers an overview of the main characteristics of the Maltese Pharmaceutical market for innovators? Hilary Agius: In a nutshell, in Malta there are two distinct markets;…
Andrew Corrieri of Pharmaconsulta in Malta outlines his consultancy’s comprehensive service offering, the opportunities inherent in the Maltese life sciences industry and his plans for the future. By overseeing…
Antonio Sommei, plant director of Amino Chemicals, the leading API manufacturer on the island of Malta, documents the impact of the recent merger with ABA Chemical Corporation on local operations,…
UMANA T1 – a patient monitoring ecosystem that uses tattoo sensor technology to measure and record heart rate and other physiological parameters – stands as one of the most innovative…
One area in which the island nation of Malta has been a first mover in embracing disruption has been its controversial entry into the global cannabinoid market. The medical cannabis…
Dino Mangion, head of Malta Operations at Medichem-Combino Pharm, has been leading the company through the harmonization of operations between Medichem and Combino Pharm and explains his strategy to increase…
Philip Pace, managing director of iCONSULT, a lean, need-driven healthcare service provider, discusses the holistic approach they provide to investors wanting to do business in Malta and international companies looking…
Joanna Gatt, managing director at Vivian Corporation, describes the key strategic focus she has set for her family’s marketing & distribution company as well as the strong values and reputation…
Noel Chircop, managing director at Eurofreight Services Ltd, explains how together with Karen Calleja, general manager and their phenomenal team, he has built Eurofreight up into one of the leading…
David Valenzia, territory senior partner at PwC Malta, gives his insights on the evolution of the healthcare industry in Malta as well as the key role of PwC in assisting…
Adrian Attard Trevisan, co-founder and CEO at Umana Medical Technologies, shares the story of the company’s creation and his goals to distribute its innovative solutions to European markets as well…
Dr. Christian Cardona, Minister for the Economy, Investment and Small Businesses shares his strategic view on the evolution of Malta, a country boasting no natural resources and limited connectivity, that…
Karl Sciberras, CEO of telecom projects, laboratory solutions and medical engineering specialist, Tektraco, discusses the company’s operations in Malta and Libya and why it is the partner of choice for…
See our Cookie Privacy Policy Here
